Here are six points:
1. The fourth quarter EPS hit $1.27, an increase of 9.5 percent year-over-year.
2. The company’s full-year adjusted earnings hit $4.37 per share, a 2 percent increase from the same time last year.
3. Medtronic’s worldwide revenues in the fourth quarter grossed $7.57 billion, an increase of 6 percent year-over-year. The top line surpassed Zacks Consensus Estimate of $7.48 billion.
4. Full-year 2016 total revenue reached $28.83 billion, a 7 percent increase from last year. The Zacks Consensus Estimate for full-year 2016 total revenue fell short at $28.75 billion.
5. Medtronic’s U.S. sales increased 4 percent year-over-year to $4.22 billion in the fourth quarter.
6. Zacks concluded the company ended fiscal 2016 strongly, but Medtronic will face significant currency headwinds in fiscal 2017.
More articles on devices:
Aurora Spine completes non-brokered private placement of 2.53M common shares: 4 key notes
Camber Capital Management’s stake in NuVasive totals $79.7M: 3 points
Tyber Medical expands to Australia: 3 things to know
